MYM Reaches Planting Stage for 120-Acre CBD-Rich Hemp Project in Nevada

VANCOUVER, British Columbia, June 13, 2019 /PRNewswire/ -- MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTCBB: MYMMF) ("MYM" or "The Company") Is pleased to announce it will begin the planting process for the 2019 growing season at its CBD-rich hemp project situated on 120-acres in Nye County, Nevada.

Further to the announcement of April 30, 2019, the previously acquired 1.6 million CBD-rich hemp seeds have been germinated, sprouted and grown into seedlings in preparation for planting. 

The 120-acre pivot (crop circle) has been prepped and is ready for planting. A crop of red clover has been planted to be used as a cover crop to protect the seedlings. All of the equipment, including the auto-planters, has been prepped and the project will now move into the planting stage.

"I am very excited to report that MYM's cultivation team was on site this week and reported that the plan is proceeding as expected," said Howard Steinberg, CEO of MYM. "The Nevada project is a key component in our strategy to create a massive CBD-rich hemp footprint around the globe with the goal of becoming one of the largest cultivators and bulk CBD isolate suppliers in the world."

The Company's Nevada project is based on a CBD-rich hemp production agreement with immediate revenue-generating potential. MYM has entered into a production agreement with Elite Ventures and invested USD $500,000 to grow one pivot of 120-acres of CBD-rich hemp in Nevada. Elite will plant, grow, and harvest the crop of which MYM is entitled to 50%.

Based on previous crops grown on the property, MYM's 50% entitlement of the estimated production is 60,000 lbs of biomass to be converted into 2,694 lbs of CBD isolate generating estimated revenue of $7.1 million for MYM by Q1 2020.

About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on the global growth of Cannabis and hemp. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD

Howard Steinberg, CEO
MYM Nutraceuticals Inc.
www.mym.ca

Keep up to date with MYM on our social media channels:
Twitter: @mymnutra
Facebook: @mymnutra
Instagram: @mymnutra

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Forward-looking statements include estimated production volumes, estimated revenues and gross profits. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

Investor Relations
Billy Casselman
+1-778-522-2261
investors@mym.ca

SOURCE MYM Nutraceuticals Inc.